Adlabs Films: So far so good - Views on News from Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Adlabs Films: So far so good

Aug 7, 2001

Adlabs Films, the film processing major declared encouraging results for 1QFY02. Net profit margin shot up by 530 basis points, inspite of considerable rise in depreciation. The rise in profit seems to be driven by mega bollywood hits during the year. As the number of prints for a particular movie increases, the incremental operating profits of the company increases considerably. The company has near monopoly in film processing business.

(Rs m)1QFY02FY01
Sales 145 464
Other Income 16 28
Expenditure 93 312
Operating Profit (EBDIT) 52 152
Operating Profit Margin (%)35.8%32.7%
Interest 1 2
Depreciation 7 12
Profit before Tax 60 165
Other Adjustments
Tax 16 50
Profit after Tax/(Loss) 44 115
Net profit margin (%)30.2%24.9%
No. of Shares (eoy) (m) 21.5 21.5
Diluted Earnings per share*8.25.4
P/E (at current price) 8.7 13.2
(*- annualised)

The Imax venture of the company has met with reasonable success contributing around Rs 18 m in the first full quarter of operation. However, the capacity utilisation rates are a cause of concern. The capacity utilisation has remained at around 45%, as against targeted utilisation rates of 55%. The capacity utilisation might improve in the current quarter (as schools in Mumbai re-opened in June). The company is talking to several schools in Maharastra for group private screening to students at concessional rates. The multiplex theatre project of the company is nearing completion and one screen out of the targeted four screens will be operational next month.

At the current market price of Rs 54, the stock is quoting at 9x its 1QFY02 annualised earnings. The Imax theatre and multiplex are expected to contribute good chunk to revenues from the third quarter of the current year. The company also seems to be cautious in its ad-spends and other marketing expenses. The film processing business of the company remains a cash cow for the company and is expected to continue to do well in the near future with bollywood lining up a string of new films, post the success of 'Lagaan' and 'Gadar'. However, the fortunes of the company are intrinsicly linked to the utilisation rates of the Imax and multiplex theaters. The company has a huge fixed cost bill for running these ventures and in case utilisation rates don't pick up, there could be considerable drop in operating margins. Further, considering that these projects will take atleast 3 years to breakeven, RoCE is expected to remain under strain.

Equitymaster requests your view! Post a comment on "Adlabs Films: So far so good". Click here!


More Views on News

Sorry! There are no related views on news for this company/sector.

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

A Stock with 700% Return Potential Comes with Additional Payoffs (Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story (Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Top 3 Nifty ETFs to Buy Now (Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.


India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms


Apr 28, 2014 (Close)


  • Track your investment in RELIANCE MEDIA WORKS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks